| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Chin Peter Scott is a Chief Medical Officer at DNLI. Recent filings cover 0 purchases and 1 sale. Those positions are worth an estimated $4.6M at current prices.
Chin Peter Scott's largest disclosed position is in DNLI as Chief Medical Officer, worth about $4.6M. The recent filings there lean toward selling, a net 1,654 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 1,654 | $22.29 | $36,867.66 | -0.8% |